kabutan

M3, Inc. projects 8% net profit growth for March 2027, announces share buyback of up to 3.0%

Fri May 1, 2026 5:05 pm JST Catalyst

M3 <2413> announced its earnings outlook for the fiscal year ending March 2027 and results for the year ended March 2026 after the market close on May 1. The company projects sales of 400 billion yen, up 13.8% year-on-year, and net profit of 53 billion yen, an increase of 7.9%. Simultaneously, M3 unveiled a share buyback program to repurchase up to 20 million shares, or 3.00% of its outstanding stock, for a maximum of 20 billion yen.

The buyback period will run from May 2 through April 30 next year. The company expects continued growth in its medical site digital transformation (DX) businesses and steady performance in career solutions for physicians and pharmacists. For the fiscal year ended March 2026, sales rose 23.3% to 351.36 billion yen, while net profit grew 21.3% to 49.1 billion yen.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles